Key result
Long-term combined antithrombotic therapy improves high-risk post-MI outcomes despite increased bleeding risk.
Answers are grounded in this paper and cite their sources.
Combined antithrombotic therapy improves outcomes in high-risk patients after myocardial infarction, though it increases bleeding risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ivo Varvařovský (2020) conducted a review in Myocardial infarction. Prolonged combined antithrombotic therapy vs. Standard therapy was evaluated. Long-term combined antithrombotic therapy improves outcomes in patients with high ischemic risk after myocardial infarction, albeit at the cost of a higher bleeding risk.
Synapse has enriched 10 related papers. Consider them for comparative context: